Gulf International Bank UK Ltd trimmed its stake in Waters Co. (NYSE:WAT – Free Report) by 1.0% during the fourth quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The firm owned 4,616 shares of the medical instruments supplier’s stock after selling 46 shares during the period. Gulf International Bank UK Ltd’s holdings in Waters were worth $1,712,000 as of its most recent SEC filing.
Several other large investors also recently made changes to their positions in the business. State Street Corp grew its holdings in shares of Waters by 1.9% during the third quarter. State Street Corp now owns 2,577,733 shares of the medical instruments supplier’s stock worth $927,700,000 after purchasing an additional 49,194 shares during the last quarter. Geode Capital Management LLC grew its holdings in shares of Waters by 1.2% during the third quarter. Geode Capital Management LLC now owns 1,416,683 shares of the medical instruments supplier’s stock worth $508,123,000 after purchasing an additional 16,703 shares during the last quarter. Janus Henderson Group PLC grew its holdings in shares of Waters by 0.7% during the third quarter. Janus Henderson Group PLC now owns 885,593 shares of the medical instruments supplier’s stock worth $318,717,000 after purchasing an additional 6,256 shares during the last quarter. Principal Financial Group Inc. grew its holdings in shares of Waters by 11.1% during the fourth quarter. Principal Financial Group Inc. now owns 728,534 shares of the medical instruments supplier’s stock worth $270,272,000 after purchasing an additional 72,515 shares during the last quarter. Finally, Impax Asset Management Group plc grew its holdings in shares of Waters by 10.6% during the fourth quarter. Impax Asset Management Group plc now owns 714,155 shares of the medical instruments supplier’s stock worth $264,937,000 after purchasing an additional 68,509 shares during the last quarter. Institutional investors own 94.01% of the company’s stock.
Wall Street Analysts Forecast Growth
Several analysts have recently commented on WAT shares. Bank of America decreased their target price on Waters from $430.00 to $410.00 and set a “neutral” rating on the stock in a report on Thursday, February 13th. Deutsche Bank Aktiengesellschaft increased their target price on Waters from $310.00 to $325.00 and gave the stock a “hold” rating in a report on Monday, November 4th. Sanford C. Bernstein upgraded Waters from a “market perform” rating to an “outperform” rating and set a $430.00 price target on the stock in a report on Friday, January 10th. UBS Group raised their price target on Waters from $405.00 to $410.00 and gave the company a “neutral” rating in a report on Thursday, February 13th. Finally, TD Cowen raised their price target on Waters from $363.00 to $410.00 and gave the company a “hold” rating in a report on Monday, November 4th. Eleven research analysts have rated the stock with a hold rating, five have issued a buy rating and one has given a strong buy rating to the stock. According to MarketBeat, the company has a consensus rating of “Hold” and an average target price of $390.40.
Waters Trading Up 1.1 %
NYSE:WAT opened at $377.22 on Friday. Waters Co. has a 1-year low of $279.24 and a 1-year high of $423.56. The business’s 50-day moving average price is $390.04 and its two-hundred day moving average price is $367.50. The company has a current ratio of 0.94, a quick ratio of 0.65 and a debt-to-equity ratio of 1.14. The firm has a market capitalization of $22.40 billion, a price-to-earnings ratio of 35.22, a PEG ratio of 3.79 and a beta of 1.01.
Waters (NYSE:WAT – Get Free Report) last released its earnings results on Wednesday, February 12th. The medical instruments supplier reported $4.10 earnings per share for the quarter, beating the consensus estimate of $4.02 by $0.08. Waters had a return on equity of 46.31% and a net margin of 21.56%. On average, equities analysts expect that Waters Co. will post 12.86 earnings per share for the current year.
About Waters
Waters Corporation provides analytical workflow solutions in Asia, the Americas, and Europe. It operates through two segments: Waters and TA. The company designs, manufactures, sells, and services high and ultra-performance liquid chromatography, as well as mass spectrometry (MS) technology systems and support products, including chromatography columns, other consumable products, and post-warranty service plans.
Recommended Stories
- Five stocks we like better than Waters
- Trading Halts Explained
- Autodesk Designs Value for Investors: Uptrend Set to Continue
- Expert Stock Trading Psychology Tips
- Anheuser-Busch Stock Rallies—Is the King of Beers Back?
- What Does Downgrade Mean in Investing?
- MarketBeat Week in Review – 02/24 – 02/28
Want to see what other hedge funds are holding WAT? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Waters Co. (NYSE:WAT – Free Report).
Receive News & Ratings for Waters Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Waters and related companies with MarketBeat.com's FREE daily email newsletter.